Literature DB >> 21037231

Hypotonic swelling-induced activation of PKN1 mediates cell survival in cardiac myocytes.

Katsuya Kajimoto1, Dan Shao, Hiromitsu Takagi, Gregorio Maceri, Daniela Zablocki, Hideyuki Mukai, Yoshitaka Ono, Junichi Sadoshima.   

Abstract

Hypotonic cell swelling in the myocardium is induced by pathological conditions, including ischemia-reperfusion, and affects the activities of ion transporters/channels and gene expression. However, the signaling mechanism activated by hypotonic stress (HS) is not fully understood in cardiac myocytes. A specialized protein kinase cascade, consisting of Pkc1 and MAPKs, is activated by HS in yeast. Here, we demonstrate that protein kinase N1 (PKN1), a serine/threonine protein kinase and a homolog of Pkc1, is activated by HS (67% osmolarity) within 5 min and reaches peak activity at 60 min in cardiac myocytes. Activation of PKN1 by HS was accompanied by Thr(774) phosphorylation and concomitant activation of PDK1, a potential upstream regulator of PKN1. HS also activated RhoA, thereby increasing interactions between PKN1 and RhoA. PP1 (10(-5) M), a selective Src family tyrosine kinase inhibitor, significantly suppressed HS-induced activation of RhoA and PKN1. Constitutively active PKN1 significantly increased the transcriptional activity of Elk1-GAL4, an effect that was inhibited by dominant negative MEK. Overexpression of PKN1 significantly increased ERK phosphorylation, whereas downregulation of PKN1 inhibited HS-induced ERK phosphorylation. Downregulation of PKN1 and inhibition of ERK by U-0126 both significantly inhibited the survival of cardiac myocytes in the presence of HS. These results suggest that a signaling cascade, consisting of Src, RhoA, PKN1, and ERK, is activated by HS, thereby promoting cardiac myocyte survival.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21037231      PMCID: PMC3023260          DOI: 10.1152/ajpheart.00232.2010

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  58 in total

1.  Characterization of the interaction between RhoA and the amino-terminal region of PKN.

Authors:  H Shibata; H Mukai; Y Inagaki; Y Homma; K Kimura; K Kaibuchi; S Narumiya; Y Ono
Journal:  FEBS Lett       Date:  1996-05-06       Impact factor: 4.124

Review 2.  Cell swelling and ion transport pathways in cardiac myocytes.

Authors:  J I Vandenberg; S A Rees; A R Wright; T Powell
Journal:  Cardiovasc Res       Date:  1996-07       Impact factor: 10.787

3.  Tyrosine kinase activation is an immediate and essential step in hypotonic cell swelling-induced ERK activation and c-fos gene expression in cardiac myocytes.

Authors:  J Sadoshima; Z Qiu; J P Morgan; S Izumo
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

4.  Activation of the osmo-sensitive chloride conductance involves P21rho and is accompanied by a transient reorganization of the F-actin cytoskeleton.

Authors:  B C Tilly; M J Edixhoven; L G Tertoolen; N Morii; Y Saitoh; S Narumiya; H R de Jonge
Journal:  Mol Biol Cell       Date:  1996-09       Impact factor: 4.138

Review 5.  In defense of cell volume?

Authors:  J C Parker
Journal:  Am J Physiol       Date:  1993-11

6.  Identification of a putative target for Rho as the serine-threonine kinase protein kinase N.

Authors:  M Amano; H Mukai; Y Ono; K Chihara; T Matsui; Y Hamajima; K Okawa; A Iwamatsu; K Kaibuchi
Journal:  Science       Date:  1996-02-02       Impact factor: 47.728

7.  A role for the Pkc1 MAP kinase pathway of Saccharomyces cerevisiae in bud emergence and identification of a putative upstream regulator.

Authors:  J V Gray; J P Ogas; Y Kamada; M Stone; D E Levin; I Herskowitz
Journal:  EMBO J       Date:  1997-08-15       Impact factor: 11.598

8.  A downstream target of RHO1 small GTP-binding protein is PKC1, a homolog of protein kinase C, which leads to activation of the MAP kinase cascade in Saccharomyces cerevisiae.

Authors:  H Nonaka; K Tanaka; H Hirano; T Fujiwara; H Kohno; M Umikawa; A Mino; Y Takai
Journal:  EMBO J       Date:  1995-12-01       Impact factor: 11.598

9.  Activation of yeast protein kinase C by Rho1 GTPase.

Authors:  Y Kamada; H Qadota; C P Python; Y Anraku; Y Ohya; D E Levin
Journal:  J Biol Chem       Date:  1996-04-19       Impact factor: 5.157

10.  A second osmosensing signal transduction pathway in yeast. Hypotonic shock activates the PKC1 protein kinase-regulated cell integrity pathway.

Authors:  K R Davenport; M Sohaskey; Y Kamada; D E Levin; M C Gustin
Journal:  J Biol Chem       Date:  1995-12-15       Impact factor: 5.157

View more
  10 in total

1.  PKN1 Directs Polarized RAB21 Vesicle Trafficking via RPH3A and Is Important for Neutrophil Adhesion and Ischemia-Reperfusion Injury.

Authors:  Qianying Yuan; Chunguang Ren; Wenwen Xu; Björn Petri; Jiasheng Zhang; Yong Zhang; Paul Kubes; Dianqing Wu; Wenwen Tang
Journal:  Cell Rep       Date:  2017-06-20       Impact factor: 9.423

2.  Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy.

Authors:  Varadha Balaji Venkadakrishnan; Adam D DePriest; Sangeeta Kumari; Dhirodatta Senapati; Salma Ben-Salem; Yixue Su; Giridhar Mudduluru; Qiang Hu; Eduardo Cortes; Elena Pop; James L Mohler; Gissou Azabdaftari; Kristopher Attwood; Rajal B Shah; Christina Jamieson; Scott M Dehm; Cristina Magi-Galluzzi; Eric Klein; Nima Sharifi; Song Liu; Hannelore V Heemers
Journal:  Oncogene       Date:  2019-02-11       Impact factor: 9.867

Review 3.  Regulation of epithelial sodium transport via epithelial Na+ channel.

Authors:  Yoshinori Marunaka; Naomi Niisato; Akiyuki Taruno; Mariko Ohta; Hiroaki Miyazaki; Shigekuni Hosogi; Ken-Ichi Nakajima; Katsuyuki Kusuzaki; Eishi Ashihara; Kyosuke Nishio; Yoshinobu Iwasaki; Takashi Nakahari; Takahiro Kubota
Journal:  J Biomed Biotechnol       Date:  2011-10-17

4.  Increase in hypotonic stress-induced endocytic activity in macrophages via ClC-3.

Authors:  Yutao Yan; Yu Ding; Bingxia Ming; Wenjiao Du; Xiaoling Kong; Li Tian; Fang Zheng; Min Fang; Zheng Tan; Feili Gong
Journal:  Mol Cells       Date:  2014-05-16       Impact factor: 5.034

5.  Protein Kinase C-Related Kinase (PKN/PRK). Potential Key-Role for PKN1 in Protection of Hypoxic Neurons.

Authors:  Bettina Thauerer; Stephanie Zur Nedden; Gabriele Baier-Bitterlich
Journal:  Curr Neuropharmacol       Date:  2014-05       Impact factor: 7.363

6.  Loss of Protein Kinase Novel 1 (PKN1) is associated with mild systolic and diastolic contractile dysfunction, increased phospholamban Thr17 phosphorylation, and exacerbated ischaemia-reperfusion injury.

Authors:  Asvi A Francois; Kofo Obasanjo-Blackshire; James E Clark; Andrii Boguslavskyi; Mark R Holt; Peter J Parker; Michael S Marber; Richard J Heads
Journal:  Cardiovasc Res       Date:  2018-01-01       Impact factor: 10.787

7.  RhoA promotes epidermal stem cell proliferation via PKN1-cyclin D1 signaling.

Authors:  Fan Wang; Rixing Zhan; Liang Chen; Xia Dai; Wenping Wang; Rui Guo; Xiaoge Li; Zhe Li; Liang Wang; Shupeng Huang; Jie Shen; Shirong Li; Chuan Cao
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

Review 8.  PKC and PKN in heart disease.

Authors:  Valeria Marrocco; Julius Bogomolovas; Elisabeth Ehler; Cristobal G Dos Remedios; Jiayu Yu; Chen Gao; Stephan Lange
Journal:  J Mol Cell Cardiol       Date:  2019-02-08       Impact factor: 5.000

Review 9.  The structure and function of protein kinase C-related kinases (PRKs).

Authors:  Georgios Sophocleous; Darerca Owen; Helen R Mott
Journal:  Biochem Soc Trans       Date:  2021-02-26       Impact factor: 5.407

10.  PKN1 kinase-negative knock-in mice develop splenomegaly and leukopenia at advanced age without obvious autoimmune-like phenotypes.

Authors:  Salman Mahmud Siddique; Koji Kubouchi; Yuka Shinmichi; Nana Sawada; Reiko Sugiura; Yasushi Itoh; Shunsuke Uehara; Kanae Nishimura; Shunsuke Okamura; Hiroyuki Ohsaki; Shingo Kamoshida; Yusuke Yamashita; Shinobu Tamura; Takashi Sonoki; Hiroshi Matsuoka; Tomoo Itoh; Hideyuki Mukai
Journal:  Sci Rep       Date:  2019-09-27       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.